
|Videos|May 25, 2016
- Gastrointestinal Cancers: mCRC (Issue 8)
Novel Targets in Gastric Cancer
Author(s)Manish Shah, MD
Manish A. Shah, MD, medical oncology, NewYork-Presbyterian/Weill Cornell discusses novel targets in gastric cancer outside of HER2.
Advertisement
Articles in this issue
about 10 years ago
Pessimism Surrounds VEGF Inhibitors in Advanced Gastric Cancerabout 10 years ago
Immunotherapies Provide Promising Results in Advanced Gastric Cancerabout 10 years ago
The Link Between Helicobacter Pylori and Gastric Cancerabout 10 years ago
Unmet Needs and Future Treatment Approaches in Gastric CancerAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Dr Cloughesy on Extended Follow-Up Data for Vorasidenib in IDH1/2 Mutant Glioma
2
Bispecific ADC Iza-Bren Extends Survival in Advanced TNBC
3
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
4
FDA Grants Priority Review to Giredestrant for ER+/HER2- Breast Cancer
5

































